{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:12:18Z","timestamp":1778393538767,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,9]]},"DOI":"10.7759\/cureus.108573","type":"journal-article","created":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:07:07Z","timestamp":1778393227000},"source":"Crossref","is-referenced-by-count":0,"title":["Palliative and Supportive Care Needs in Advanced Hidradenitis Suppurativa: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Muhammad A","family":"Almahdi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany","family":"Mashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali Y","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayar M","family":"Alahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meshari A","family":"Alalyani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manar S","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shorooq  A","family":"Hamzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2021.1677","article-title":"Prevalence of hidradenitis suppurativa: a systematic review and meta-regression analysis","volume":"157","author":"Jfri A","year":"2021","unstructured":"Jfri A, Nassim D, O'Brien E, Gulliver W, Nikolakis G, Zouboulis CC. Prevalence of hidradenitis suppurativa: a systematic review and meta-regression analysis. JAMA Dermatol. 2021, 157:924-31. 10.1001\/jamadermatol.2021.1677","journal-title":"JAMA Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s41702-019-0052-0","article-title":"Global prevalence of hidradenitis suppurativa and geographical variation - systematic review and meta-analysis","volume":"4","author":"Phan K","year":"2020","unstructured":"Phan K, Charlton O, Smith SD. Global prevalence of hidradenitis suppurativa and geographical variation - systematic review and meta-analysis. Biomed Dermatol. 2020, 4:2. 10.1186\/s41702-019-0052-0","journal-title":"Biomed Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat R","year":"2020","unstructured":"Sabat R, Jemec GB, Matusiak \u0141, Kimball AB, Prens E, Wolk K. Hidradenitis suppurativa. Nat Rev Dis Primers. 2020, 6:18. 10.1038\/s41572-020-0149-1","journal-title":"Nat Rev Dis Primers"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.0164","article-title":"Comparative overall comorbidity burden among patients with hidradenitis suppurativa","volume":"155","author":"Reddy S","year":"2019","unstructured":"Reddy S, Strunk A, Garg A. Comparative overall comorbidity burden among patients with hidradenitis suppurativa. JAMA Dermatol. 2019, 155:797-802. 10.1001\/jamadermatol.2019.0164","journal-title":"JAMA Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2019.0759","article-title":"Depression and anxiety in adults with hidradenitis suppurativa: a systematic review and meta-analysis","volume":"155","author":"Machado MO","year":"2019","unstructured":"Machado MO, Stergiopoulos V, Maes M, et al.. Depression and anxiety in adults with hidradenitis suppurativa: a systematic review and meta-analysis. JAMA Dermatol. 2019, 155:939-45. 10.1001\/jamadermatol.2019.0759","journal-title":"JAMA Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2017.09.008","article-title":"Increased suicide risk in patients with hidradenitis suppurativa","volume":"138","author":"Thorlacius L","year":"2018","unstructured":"Thorlacius L, Cohen AD, Gislason GH, Jemec GB, Egeberg A. Increased suicide risk in patients with hidradenitis suppurativa. J Invest Dermatol. 2018, 138:52-7. 10.1016\/j.jid.2017.09.008","journal-title":"J Invest Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.07.027","article-title":"Uncovering burden disparity: a comparative analysis of the impact of moderate-to-severe psoriasis and hidradenitis suppurativa","volume":"77","author":"Hamzavi IH","year":"2017","unstructured":"Hamzavi IH, Sundaram M, Nicholson C, et al.. Uncovering burden disparity: a comparative analysis of the impact of moderate-to-severe psoriasis and hidradenitis suppurativa. J Am Acad Dermatol. 2017, 77:1038-46. 10.1016\/j.jaad.2017.07.027","journal-title":"J Am Acad Dermatol"},{"key":"ref8","unstructured":"Palliative care. (2020). Accessed. May 8, 2026: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/palliative-care."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2020.04.027","article-title":"Redefining palliative care - a new consensus-based definition","volume":"60","author":"Radbruch L","year":"2020","unstructured":"Radbruch L, De Lima L, Knaul F, et al.. Redefining palliative care - a new consensus-based definition. J Pain Symptom Manage. 2020, 60:754-64. 10.1016\/j.jpainsymman.2020.04.027","journal-title":"J Pain Symptom Manage"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021, 372:n71. 10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17386","article-title":"Exploring racial and ethnic disparities in the hidradenitis suppurativa patient disease journey: results from a real-world study in Europe and the USA","volume":"51","author":"Jaleel T","year":"2024","unstructured":"Jaleel T, Mitchell B, Burge R, et al.. Exploring racial and ethnic disparities in the hidradenitis suppurativa patient disease journey: results from a real-world study in Europe and the USA. J Dermatol. 2024, 51:1547-58. 10.1111\/1346-8138.17386","journal-title":"J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: results from the global survey of impact and healthcare needs (VOICE) project","volume":"82","author":"Garg A","year":"2020","unstructured":"Garg A, Neuren E, Cha D, et al.. Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: results from the global survey of impact and healthcare needs (VOICE) project. J Am Acad Dermatol. 2020, 82:366-76. 10.1016\/j.jaad.2019.06.1301","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16642","article-title":"Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa","volume":"34","author":"Gergely LH","year":"2020","unstructured":"Gergely LH, G\u00e1sp\u00e1r K, Brodszky V, et al.. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2020, 34:2584-92. 10.1111\/jdv.16642","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18163","article-title":"Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US","volume":"36","author":"Ingram JR","year":"2022","unstructured":"Ingram JR, Bettoli V, Espy JI, et al.. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US. J Eur Acad Dermatol Venereol. 2022, 36:1597-605. 10.1111\/jdv.18163","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16132","article-title":"Baseline patient-reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice","volume":"34","author":"Kimball AB","year":"2020","unstructured":"Kimball AB, Crowley JJ, Papp K, Calimlim B, Duan Y, Fleischer AB, Sobell J. Baseline patient-reported outcomes from UNITE: an observational, international, multicentre registry to evaluate hidradenitis suppurativa in clinical practice. J Eur Acad Dermatol Venereol. 2020, 34:1302-8. 10.1111\/jdv.16132","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.729104","article-title":"Sexuality in persons with hidradenitis suppurativa: factors associated with sexual desire and functioning impairment","volume":"12","author":"Quinto RM","year":"2021","unstructured":"Quinto RM, Mastroeni S, Sampogna F, Fania L, Fusari R, Iani L, Abeni D. Sexuality in persons with hidradenitis suppurativa: factors associated with sexual desire and functioning impairment. Front Psychiatry. 2021, 12:729104. 10.3389\/fpsyt.2021.729104","journal-title":"Front Psychiatry"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljaf067","article-title":"Psychometric validation and interpretation thresholds of the hidradenitis suppurativa quality of life (HiSQOL\u00a9) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa","volume":"193","author":"Kirby JS","year":"2025","unstructured":"Kirby JS, Thorlacius L, Lambert J, et al.. Psychometric validation and interpretation thresholds of the hidradenitis suppurativa quality of life (HiSQOL\u00a9) questionnaire using pooled data from the phase III BE HEARD I & II trials of bimekizumab in hidradenitis suppurativa. Br J Dermatol. 2025, 193:93-104. 10.1093\/bjd\/ljaf067","journal-title":"Br J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.3282","article-title":"Outcome measures for the evaluation of treatment response in hidradenitis suppurativa for clinical practice: a HiSTORIC consensus statement","volume":"159","author":"Mastacouris N","year":"2023","unstructured":"Mastacouris N, Tannenbaum R, Strunk A, et al.. Outcome measures for the evaluation of treatment response in hidradenitis suppurativa for clinical practice: a HiSTORIC consensus statement. JAMA Dermatol. 2023, 159:1258-66. 10.1001\/jamadermatol.2023.3282","journal-title":"JAMA Dermatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18692","article-title":"The hidradenitis suppurativa quality of life (HiSQOL) score: development and validation of a measure for clinical trials","volume":"183","author":"Kirby JS","year":"2020","unstructured":"Kirby JS, Thorlacius L, Villumsen B, et al.. The hidradenitis suppurativa quality of life (HiSQOL) score: development and validation of a measure for clinical trials. Br J Dermatol. 2020, 183:340-8. 10.1111\/bjd.18692","journal-title":"Br J Dermatol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16672","article-title":"A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process","volume":"179","author":"Thorlacius L","year":"2018","unstructured":"Thorlacius L, Ingram JR, Villumsen B, et al.. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process. Br J Dermatol. 2018, 179:642-50. 10.1111\/bjd.16672","journal-title":"Br J Dermatol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis CC","year":"2015","unstructured":"Zouboulis CC, Desai N, Emtestam L, et al.. European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol. 2015, 29:619-44. 10.1111\/jdv.12966","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2308","article-title":"Pain in hidradenitis suppurativa: a pilot study","volume":"96","author":"Ring HC","year":"2016","unstructured":"Ring HC, S\u00f8rensen H, Miller IM, List EK, Saunte DM, Jemec GB. Pain in hidradenitis suppurativa: a pilot study. Acta Derm Venereol. 2016, 96:554-6. 10.2340\/00015555-2308","journal-title":"Acta Derm Venereol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.02.053","article-title":"Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"79","author":"Garg A","year":"2018","unstructured":"Garg A, Papagermanos V, Midura M, Strunk A, Merson J. Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population-based analysis in the United States. J Am Acad Dermatol. 2018, 79:495-500.e1. 10.1016\/j.jaad.2018.02.053","journal-title":"J Am Acad Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-1082","article-title":"Psychosocial impact of hidradenitis suppurativa: a qualitative study","volume":"91","author":"Esmann S","year":"2011","unstructured":"Esmann S, Jemec GB. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol. 2011, 91:328-32. 10.2340\/00015555-1082","journal-title":"Acta Derm Venereol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-021-00539-7","article-title":"Identifying unmet care needs and important treatment attributes in the management of hidradenitis suppurativa: a qualitative interview study","volume":"15","author":"Willems D","year":"2022","unstructured":"Willems D, Hiligsmann M, van der Zee HH, Sayed CJ, Evers SM. Identifying unmet care needs and important treatment attributes in the management of hidradenitis suppurativa: a qualitative interview study. Patient. 2022, 15:207-18. 10.1007\/s40271-021-00539-7","journal-title":"Patient"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14038","article-title":"Diagnostic delay in hidradenitis suppurativa is a global problem","volume":"173","author":"Saunte DM","year":"2015","unstructured":"Saunte DM, Boer J, Stratigos A, et al.. Diagnostic delay in hidradenitis suppurativa is a global problem. Br J Dermatol. 2015, 173:1546-9. 10.1111\/bjd.14038","journal-title":"Br J Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000508787","article-title":"Delayed diagnosis of hidradenitis suppurativa and its effect on patients and healthcare system","volume":"236","author":"Kokolakis G","year":"2020","unstructured":"Kokolakis G, Wolk K, Schneider-Burrus S, Kalus S, Barbus S, Gomis-Kleindienst S, Sabat R. Delayed diagnosis of hidradenitis suppurativa and its effect on patients and healthcare system. Dermatology. 2020, 236:421-30. 10.1159\/000508787","journal-title":"Dermatology"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-022-02507-z","article-title":"Racial disparities in dermatology","volume":"315","author":"Narla S","year":"2023","unstructured":"Narla S, Heath CR, Alexis A, Silverberg JI. Racial disparities in dermatology. Arch Dermatol Res. 2023, 315:1215-23. 10.1007\/s00403-022-02507-z","journal-title":"Arch Dermatol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/484216-palliative-and-supportive-care-needs-in-advanced-hidradenitis-suppurativa-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T06:07:08Z","timestamp":1778393228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/484216-palliative-and-supportive-care-needs-in-advanced-hidradenitis-suppurativa-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,9]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.108573","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,9]]}}}